Gsk Plc
Holdings as of Mar 31, 2026 · filed May 14, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Crispr Therapeutics Ag | $153205226 | 25.57% | — | NEW BUY |
| 2 | Wave Life Sciences Ltd | $132281260 | 22.08% | — | NEW BUY |
| 3 | Biontech Se | $79087557 | 13.20% | — | NEW BUY |
| 4 | Vir Biotechnology Inc | $76616548 | 12.79% | — | NEW BUY |
| 5 | Ideaya Biosciences Inc | $44426656 | 7.41% | — | NEW BUY |
| 6 | Lyell Immunopharma Inc | $30343940 | 5.06% | — | NEW BUY |
| 7 | Cytokinetics Inc | $22438005 | 3.74% | — | NEW BUY |
| 8 | Spero Therapeutics Inc | $21506018 | 3.59% | — | NEW BUY |
| 9 | Fulcrum Therapeutics Inc | $13696426 | 2.29% | — | NEW BUY |
| 10 | Cvrx Inc | $9531735 | 1.59% | — | NEW BUY |
| 11 | Bicycle Therapeutics Plc | $7097163 | 1.18% | — | NEW BUY |
| 12 | Nkarta Inc | $6648045 | 1.11% | — | NEW BUY |
| 13 | Regenxbio Inc | $2274801 | 0.38% | — | NEW BUY |
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.